Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, Peterlin BM.
J Virol. 2004 Jun;78(11):6073-6.
Related citations
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Liddament MT, Brown WL, Schumacher AJ, Harris RS.
Curr Biol. 2004 Aug 10;14(15):1385-91.
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
Zennou V, Bieniasz PD.
Virology. 2006 May 25;349(1):31-40. Epub 2006 Feb 7.
Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF.
J Virol. 2006 Mar;80(6):3112-5.
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.
Franca R, Spadari S, Maga G.
Med Sci Monit. 2006 May;12(5):RA92-8. Review.
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.
Wichroski MJ, Robb GB, Rana TM.
PLoS Pathog. 2006 May;2(5):e41. Epub 2006 May 12.
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.
Pace C, Keller J, Nolan D, James I, Gaudieri S, Moore C, Mallal S.
J Virol. 2006 Sep;80(18):9259-69. Erratum in: J Virol. 2007 Aug;81(16):8843-5.
Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.
Jónsson SR, Haché G, Stenglein MD, Fahrenkrug SC, Andrésdóttir V, Harris RS.
Nucleic Acids Res. 2006;34(19):5683-94. Epub 2006 Oct 11.
Natural resistance to HIV infection: The Vif-APOBEC interaction.
Malim MH.
C R Biol. 2006 Nov;329(11):871-5. Epub 2006 Aug 17.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on